Loading...

A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or Higher

BACKGROUND: Studies of octreotide in hepatocellular carcinoma have yielded conflicting results. Since past studies have excluded patients with highly advanced disease and given the fact that octreotide offers several potential physiologic benefits in patients with advanced cirrhosis, such as improvi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Shah, Usman, O’Neil, Bert, Allen, Jill, Goldberg, Richard M., Bernard, Steven, Moore, Dominic, Venook, Alan P., Morse, Michael M.
Format: Artigo
Sprog:Inglês
Udgivet: International Society of Gastrointestinal Oncology 2009
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2684718/
https://ncbi.nlm.nih.gov/pubmed/19461906
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!